Global Respiratory Inhalers Market Growth Accelerated by Increased Prevalence of Respiratory Diseases

Sneha

Global Respiratory Inhalers Market Growth Accelerated by Increased Prevalence of Respiratory Diseases

Respiratory inhalers are medical devices used for the delivery of medications through inhalation to treat respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Inhalers offer quicker delivery of drugs to the respiratory system compared to oral medications and cause fewer side effects. With the increasing prevalence of respiratory diseases due to pollution, smoking, and aging population, the need for respiratory inhalers has accelerated.

The global Respiratory Inhalers Market is estimated to be valued at US$ 35 billion in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023–2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends fueling the growth of the respiratory inhalers market is the rising prevalence of respiratory diseases. As per the WHO, over 235 million people suffer from asthma worldwide, and incidence and prevalence of asthma are rising globally. Additionally, the International COPD Coalition reports that COPD is the third leading cause of death globally. Pollution levels are worsening air quality globally resulting in many respiratory issues. The increasing pollution and aging population are contributing to the rising prevalence of respiratory diseases, thereby driving the demand for respiratory inhalers that help manage the symptoms of these diseases. With growing awareness about respiratory diseases and availability of various inhalers, this trend is expected to continue over the forecast period.

Segment Analysis

The global respiratory inhalers market is segmented by product into dry powder inhalers (DPIs), metered dose inhalers (MDIs), and nebulizers. Among these, DPIs dominate the market due to their ease of use and high degree of portability. DPIs do not require coordinating an actuation with inspiration and require minimal hand-breath coordination skills. This makes them well suited for both children and adults.

Key Takeaways

The Global Respiratory Inhalers Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The global Respiratory Inhalers Market is estimated to be valued at US$ 41.2 billion in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023–2030.

Regional analysis:

North America is expected to continue dominating the respiratory inhalers market during the forecast period. Rising cases of COPD and asthma are major factors driving market growth in the region. According to the Center for Disease Control and Prevention (CDC), in 2020 around 25 million Americans suffered from asthma. Presence of well-established healthcare infrastructure and favorable reimbursement policies in the US and Canada are also boosting adoption of respiratory inhalers.

Key players:

Key players operating in the respiratory inhalers market are GlaxoSmithKline Plc, Novartis AG, Merck & Co., AstraZeneca Plc, Boehringer Ingelheim GmbH. GlaxoSmithKline Plc holds the leading market position owing to its wide product portfolio of inhalers for conditions like asthma and COPD. Novartis AG is another major player focusing on developing novel respiratory drugs and devices.

Explore more information on this topic, Please visit -

https://www.insightprobing.com/respiratory-inhalers-market-share-and-demand-analysis/

Explore more trending article related this topic -

https://masstamilan.in/procurement-outsourcing-a-viable-option-to-reduce-costs-and-improve-efficiencies/

Sneha

Respiratory Inhalers Market is Estimated to Witness High Growth Owing to Increased Demand for Portable Inhalers

Rajkumar cmi 2024-02-08

The global Respiratory Inhalers Market is estimated to be valued at US$ 34. Segment Analysis Dry powder inhalers is expected to dominate the respiratory inhalers market size during the forecast period. Key Takeaways The global Respiratory Inhalers market is expected to witness high growth. The global Respiratory Inhalers Market is estimated to be valued at US$ 34. The North America respiratory inhalers market is expected to hold the largest market share during the forecast period. Key players operating in the Respiratory Inhalers market are Simpson Strong-Tie Co.

Respiratory Inhalers Is Estimated To Witness High Growth Owing To Opportunity For Treating Respiratory Diseases

Leena Shedmake 2024-01-22

There are two main types of respiratory inhalers: metered-dose inhalers and dry powder inhalers. The global respiratory inhalers market is estimated to be valued at US$ 44,200 million in 2023 and is expected to exhibit a CAGR of 5. The increasing cases of respiratory illnesses is driving the demand for effective therapeutic solutions such as respiratory inhalers for treatment. Threat of new substitutes: The threat from substitutes is low as respiratory inhalers are considered the standard treatment for respiratory diseases. Key players operating in the respiratory inhalers market are GlaxoSmithKline, Novartis AG, Merck & Co, Boehringer Ingelheim, AstraZeneca and Teva Pharmaceutical.

Respiratory Inhalers Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Respiratory Diseases

Vedant B 2024-03-12

The Global respiratory inhalers market is estimated to be valued at US$ 34. Segment AnalysisDry powder inhalers segment currently dominates the respiratory inhalers market. Global Analysis North America region is expected to continue its dominance in the respiratory inhalers market during the forecast period. High patient awareness about inhalation therapy and availability of advanced inhalers drive the North America respiratory inhalers market. Get more insights on Respiratory Inhalers Market

Respiratory Inhalers Market Are Estimated To Witness High Growth Owing To Rise In Respiratory Disorders

Poonam 2023-12-29

The global respiratory inhalers market is estimated to be valued at US$ 29. The continued demand for maintenance therapies amongst patients suffering from chronic respiratory diseases is expected to drive the market growth of respiratory inhalers over the forecast period. Key Takeaways The global Respiratory Inhalers Market Share is expected to witness high growth over the forecast period supported by rising asthma, COPD prevalence worldwide. Key players operating in the respiratory inhalers market are Unilever, Procter & Gamble, Reckitt Benckiser, Henkel AG & Co. The future of the market is expected to be shaped by the development of respiratory inhalers devices featuring increased efficiency, portability and connectivity.

The Growing Demand for Respiratory Inhalers Market

Ben Wood 2023-04-21

The demand for respiratory inhalers has been on the rise in recent years, owing to the growing prevalence of respiratory diseases and the increasing adoption of inhalers as a preferred mode of treatment. The rising geriatric population, growing pollution levels, and lifestyle changes have further contributed to the increasing demand for respiratory inhalers. The introduction of smart inhalers, which can track the usage of inhalers and provide feedback to patients and healthcare professionals, has also contributed to the growing demand for respiratory inhalers. Overall, the growing demand for respiratory inhalers market is expected to continue in the coming years, driven by the increasing prevalence of respiratory diseases and the availability of innovative inhaler formulations. The Asia Pacific market is estimated to witness significant growth in the global respiratory inhalers market, owing to factors such as the increasing prevalence of respiratory diseases, rising healthcare expenditure, and growing adoption of combination therapies for respiratory diseases.

Respiratory Inhalers Market by Type, Applications, Growth Drivers, Trends, Demand 2030

john warne 2023-02-23

The global Respiratory Inhalers Market is on high pace owing to rapid increase in respiratory diseases. There are key drivers that is driving the growth of the respiratory inhalers market. Key Playersthe Respiratory Inhalers Market Players include Teva Pharmaceutical Industries Ltd, Propeller Health, GSK plc, Chiesi Farmaceuti S. By type, the global market on the respiratory inhalers can be segmented on the basis of manually-operated and digitally-operated. By end user, the report on the respiratory inhalers market includes respiratory care center, hospitals & clinics, and others.

WHO TO FOLLOW

MORE FROM AUTHOR

Security at Your Fingertips: Swipe Sensors for Enhanced User Authentication

Sneha 10m

Exploring Global Demand and Regional Dynamics in the Gemigliptin Market

Sneha 40m

Beyond Headlights: Unveiling Hidden Hazards with Automotive Night Vision Systems

Sneha 2h

Unveiling the Achilles' Heel: Predicting Protein Stability Changes with AI

Sneha 2h

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

COPD Segment to Dominate the India Respiratory Inhalers Market by FY2027

Nirbhay Kulshrestha 2023-03-22

Browse XX Figures spread through XX Pages and an in-depth TOC on “India Respiratory Inhalers Market”. Manually operated inhalers are dominating the respiratory inhalers market for the forecast period as digital technology is still at developing stage. , 3M India ltd, Glenmark Pharmaceuticals Limited, Merck India are the leading players operating in the India respiratory inhalers market. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the India respiratory inhalers market. com Web: https://www.

Global Dry Powder Inhalers Market Report 2020 Forecast to 2025

Sonam Shaha 2020-07-27

The latest trending report Global Dry Powder Inhalers Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis. The report will assist reader with better understanding and decision making. The global Dry Powder Inhalers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.7% in the forecast period of 2020 to 2025 and will expected to reach USD 3526.7 million by 2025, from USD 3293.8 million in 2019. The Dry Powder Inhalers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Final Report will cover the impact of COVID-19 on this industry. Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/41612-dry-powder-inhalers-industry-analysis-report The major players covered in Dry Powder Inhalers are: Milliken Trevira Mount Vernon Tencate Klopman DowDuPont Safety Components Carrington SSM Industries Gore Waubridge Specialty Fabrics Kermel Delcotex Xinxiang Yulong Schuemer Arvind ITI Xinxiang Xinxing Glen Raven Marina Textil SRO Protective Xinxiang Xinke Xinxiang Yijia Xinxiang Jinghong Xinxiang Patron Saint Special Fabric Xinxiang Zhuocheng Hangzhou Xiangjun By Type, Dry Powder Inhalers market has been segmented into Inherent Flame Retardant Fabric Treated Flame Retardant Fabric By Application, Dry Powder Inhalers has been segmented into Clothing Home Textiles Public Utility Others The report offers in-depth assessment of the growth and other aspects of the Dry Powder Inhalers market in important countries (regions), including: North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Download Free Sample Report of Global Dry Powder Inhalers Market @ https://www.decisiondatabases.com/contact/download-sample-41612 The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Dry Powder Inhalers product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Dry Powder Inhalers, with price, sales, revenue and global market share of Dry Powder Inhalers in 2018 and 2019.Chapter 3, the Dry Powder Inhalers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Dry Powder Inhalers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Dry Powder Inhalers market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Dry Powder Inhalers sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Respiratory Inhalers Market 2019 - Growth, Analysis, Size and Share to 2023

Diksha Pote 2020-02-03

Respiratory Inhalers Market Share, Trends And Growth Analysis, By Type (Manually Operated, Digitally Operated), By Product (Dry Powder Inhaler, Metered Dose Inhaler, And Others), By Application (Asthma, Copd, And Other), By End User (Hospitals & Clinics, Respiratory Care Center, And Other) - Forecast To 2023Global Respiratory Inhaler Market – OverviewRespiratory Inhalers are medical devices that are used to assist a patient encountering breathing problems resulting from respiratory disorders such as fibrosis, asthma, COPD and ARDS and others.

Various restraints, which are restricting the market growth includes side effects and complications during inhalation, high prices of devices, and lack of accuracy etc.It is observed during recent years that patients are shifting towards combined therapies such as bronchodilator therapy for the treatment of COPD and various others, due to accompanying benefits such as more reliable in complex patients, increased efficacy and easy reimbursement policies linked with therapy.It is also observed that these combination therapies are more affective for long term control of COPD and other respiratory diseases.

These therapies cost more compared to conventional therapies for patients with complex signs of respiratory disease or disorders.

On the basis of product, the market is segmented into dry powder inhaler, metered dose inhaler, and others.

Hospitals & clinics dominated the global market with the largest market share of the total market in 2016.Global Respiratory Inhaler Market - Key FindingThe Respiratory Inhalers Market and is expected to reach $33,572.9 million by 2023.Manually Operated Inhalers holds the largest share of 89.9% of the market.North America holds the largest market share of respiratory Inhalers market and is anticipated to reach $11,949.4 million by the end of forecast period.Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 6.7% during the forecast period.Global Respiratory Inhaler Market - Regional AnalysisRespiratory Inhalers Market is segmented on the basis of geographies or regions which mainly includes North America, Europe, Asia Pacific, and Rest of the world.Currently the largest market share of global respiratory inhalers market is captured by North America, majorly due to large population among adult and kids being diagnosed with the disease like asthma and COPD in the region.

This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD.

Smart Inhalers Market Analysis | Size, Share, Global Demand and Industry Forecast 2027

VPR 2022-04-21

The subtleties canvassed in the smart inhalers market report cover every one of the parts of the business. The presentation of the smart inhalers market has likewise been read up for the past and current years. The smart inhalers market segmental examination gave in the report offers significant insights concerning the smart inhalers market presentation and future. Nonetheless, the smart inhalers market development can be impacted because of absence of mindfulness in regards to the side effects. The organization profiles of numerous associations working in the smart inhalers market report features significant subtleties like organization size, income development, and subtleties of consolidations and acquisitions occurring in the smart inhalers market.

Smart Inhalers Market: Overcoming Challenges For Widespread Adoption

sachin sadgir 2023-07-19

The Smart Inhalers Market has witnessed remarkable growth in recent years, but certain challenges hinder its widespread adoption. One of the primary challenges is the cost associated with smart inhalers. However, as the technology matures and becomes more widespread, we can expect the cost to decrease, making smart inhalers more accessible to all. As technology continues to advance, the Smart Inhalers Market will likely witness further innovation, empowering millions of individuals to breathe easier and lead healthier lives. while the Smart Inhalers Market holds tremendous promise for improving respiratory healthcare, addressing cost concerns, ensuring data security, promoting interoperability, and fostering patient engagement are essential steps to overcome challenges and drive widespread adoption.

Smart Inhalers Market Size, Share, Key Players, Trends & Forecast Till 2027

Jason Miller 2022-02-09

As per smart inhalers market analysts, the smart inhalers market based companies will face certain challenges during the 2019 to 2023. The smart inhalers market report offers comprehensive study of the smart inhalers market segments including type, application, and end user. The global smart inhalers market research report presents key company profiles of organizations active across the smart inhalers market. The smart inhalers market report covers all these key regions including the Middle East, Africa, Brazil, and others active in the global smart inhalers market. As the smart inhalers market report suggests that the smart inhalers market will register a CAGR of 45.

Improvement In Cognitive Empathy to Drive The Smart Inhalers Market

Jayprakash Sharma 2022-03-30

The Smart Inhalers Market is expected to grow on an irrevocable note in the upcoming period. This updated analysis on the smart inhalers market by Persistence Market Research predicts the industry to surge ahead at a CAGR of 23. com/methodology/26881Key Takeaways from Market StudyThe smart inhalers industry is predicted to expand at an impressive CAGR of 23. By 2031, the global smart inhalers market is predicted to be worth over US$ 1 Bn. About us: Persistence Market ResearchContact us:Persistence Market Research Address – 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.

Smart Inhalers market Drivers, Opportunities, Trends, and Forecasts

Ashish Mandar 2020-10-31

This report on the Global Smart Inhalers Market provides a global 360-degree perspective of the industry while taking into consideration historical data as well as providing accurate estimations of the future scope of the market.

It highlights key factors impacting the market growth and also contains an entire section describing the segmentation of the market on the basis of several factors such as types, applications at a high level and also points out the segments leading the market.

This makes it easier for the stakeholders of the report to utilize this information and incorporate changes in their business policies and be well informed about the market dynamics.

It also provides an insight into the competitive landscape of the market highlighting key competitors, major manufacturers dominating the Smart Inhalers Market, while also providing an analysis of the market share and revenue generation figures.Ask for report free sample with complete TOC and list of tables/figures @ https://www.datalibraryresearch.com/sample-request/smart-inhalers-market-2186Global Smart Inhalers Market Competitive Analysis:AdheriumAstraZenecaBoehringer IngelheimCohero HealthGlaxo Smith KlineNovartis International AGOpko HealthResMed, Inc.Teva Pharmaceutical Industries LimitedVectura Group plc.Drivers & ConstraintsThe report largely stresses on the importance of market dynamics in understanding the Smart Inhalers Market industry.

Sales revenues, population, production rates, consumption rates, existence of key manufacturers in regions are all points that have been touched base upon in the report providing an overall comparison of each of the regions covered in the report.

Additionally, the report also calls out regions that have showed maximum growth in the past as well as regions that emerged as leaders of the market in historic years.

Respiratory Inhalers Market research,Business Opportunities, Sales and Revenue, Supply Chain, Challenges by 2030

steve miller 2023-01-27

The global Respiratory Inhalers Market Report is on high pace owing to rapid increase in respiratory diseases. There are key drivers that is driving the growth of the respiratory inhalers market Insights. By end user, the report on the respiratory inhalers market Size includes respiratory care center, hospitals & clinics, and others. Key Players the Respiratory Inhalers Market Players include Teva Pharmaceutical Industries Ltd, Propeller Health, GSK plc, Chiesi Farmaceuti S. About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

Most Detailed Research Report Smart Inhalers Market 2022 Industry Insights, Market Trends, Opportunities, Market Share.

Nikhil Ghodse 2022-06-13

According to The Insight Partners market research study titled ‘Smart Inhalers Market to 2027 – Global Analysis and Forecasts by Product, Disorder and End User. The report highlights the trends prevalent in the global smart inhalers market and the factors driving the market along with those that act as deterrents to its growth. com/sample/TIPRE00004568/The major players operating in the smart inhalers market include GlaxoSmithKline plc, Adherium Ltd. com/discount/TIPRE00004568/Global smart inhalers market, based on the product, was segmented as, nebulizers and inhalers. The report segments the global smart inhalers market as follows:Global Smart Inhalers Market – By ProductInhalersNebulizersGlobal Smart Inhalers Market – By DisorderAsthmaChronic Obstructive Pulmonary Disease (COPD) Global Smart Inhalers Market – By End UserHome-Care SettingsHospitals & ClinicsGlobal Smart Inhalers Market – By GeographyNorth AmericaUSCanadaMexicoEuropeFranceGermanyU.

Respiratory Inhaler Market Estimated To Reach Us$ 28.2 Billion By 2023

Ashish Thapa 2023-10-16

The rising prevalence of respiratory diseases, increasing air pollution levels, and the growing aging population are driving the demand for respiratory inhalers globally. The global Respiratory Inhaler Market Demand is estimated to be valued at US$ 28. Segment Analysis:The respiratory inhaler market can be segmented based on product type, technology, application, and end-user. MDIs are used by patients of all ages, including children and the elderly, making them the dominating sub-segment in the respiratory inhaler market. In terms of regional analysis, North America is the fastest-growing and dominating region in the respiratory inhaler market.

Enhancing Asthma Management: Insights into the Smart Inhalers Market

Yashvi Gadhiya 2023-07-21

Despite advancements in Smart Inhalers Market medical treatment, managing asthma remains a significant challenge for both patients and healthcare providers. However, the emergence of smart inhalers is revolutionizing asthma management, offering innovative solutions to improve treatment adherence, monitoring, and overall patient outcomes. By capturing and analyzing this data, smart inhalers empower patients to take a more proactive role in their asthma management. One of the key features of Smart Inhalers Market is medication adherence tracking. The smart inhalers market is experiencing rapid growth due to the increasing prevalence of asthma and the rising demand for personalized healthcare solutions.

Smart Inhalers Market Size Analysis, Drivers, Restraints, Key Factors Forecast 2023–2032

Tani Shah 2023-12-27

The latest report, titled ‘Global Smart Inhalers Market,’ comprises a profound analysis of the fundamental parameters contributing to the global Smart Inhalers market scenario. Its panoramic view of the Smart Inhalers industry entails useful insights into the estimated Smart Inhalers market size, revenue share, and sales & distribution networks. , South Africa, Rest of MEA)Research Report on the Smart Inhalers Market Addresses the Following Key Questions:Who are the dominant players of the Smart Inhalers market? What consumer trends and demands are expected to influence the operations of the market players in the Smart Inhalers market? What are the key growth drivers and restraining factors of the Smart Inhalers market?

Smart Inhalers Market is expected to reach US$ 8,033.21 Mn in 2027

Kanak Khera 2019-07-09

The global smart inhalers market is expected to reach US$ 8,033.21 Mn in 2027 from US$ 1,094.26 Mn in 2018.

However, risks associated with cyber threats and limited knowledge regarding the use of smart inhalers may limit the growth of the market to a certain extent.Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of Smart Inhalers Market Report Smart inhalers are used for the treatment of respiratory disorders such as asthma and COPD.

With each inhalation with the help of an inhaler, the device delivers a decided amount of medication to the lungs.

This applies equally to both metered dose inhalers (MDIs) as well as dry powder inhalers (DPIs), leading to poor disease control along with increased healthcare costs.Studies reveal due to a patients error in drug intake occur approximately 70 percent to 90 percent of the time, which results in only 7 percent to 40 percent of the drug being delivered to the lungs.

An error related to the coordination between inhalation and the release of drugs through the drug is a commonly observed error among the patients.

Improper inhalation technique causes decreased efficacy through reduced deposition of drug in the lungs, eventually leading to an increase in the rate of disease severity and therefore causing an increase in healthcare costs.